ReAlta Presents New Phase 2 Data in aGVHD
By Daniella Parra ReAlta Life Sciences’ Pegtarazimod demonstrated significant clinical improvement and reduction in inflammatory...

By Daniella Parra ReAlta Life Sciences’ Pegtarazimod demonstrated significant clinical improvement and reduction in inflammatory...
By Karen Roman March Biosciences said it appointed Gurpreet Ratra, Ph.D., as Chief Business Officer. Dr....
By Karen Roman Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS) said it is presenting new research at...
By Karen Roman ReAlta Life Sciences, Inc. announced the designation of Howard Berman, Ph.D., as Executive...
By Daniella Parra Sequana Medical said the first implantation of the alfapump in the U.S....
By Karen Roman Imviva Biotech said it will present its progress in allogenic cell therapy...
By Daniella Parra March Biosciences said that the FDA granted regenerative medicine advanced therapy its first-in-class...
By Daniella Parra Radiant Biotherapeutics presented data from their advancing a breakthrough antibody approach, the...
By Karen Roman Agilent Technologies, Inc. (NYSE: A) said it appointed Adam S. Elinoff as...
By Karen Roman Biopharmaceutical company Medera Inc. said the first patient has been dosed in...